Adrenolytic and vasodilator therapy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D001775:Blood Circulation / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use*; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000139:chemically induced; D005292:Ferricyanides / Q000627:therapeutic use; D006145:Guanethidine / Q000009:adverse effects / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D006973:Hypertension / Q000188:drug therapy*; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008177:Lupus Vulgaris / Q000139:chemically induced; D008297:Male; D008606:Mental Processes / Q000187:drug effects; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use; D008914:Minoxidil / Q000009:adverse effects; D009569:Nitric Oxide / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects; D012110:Reserpine / Q000009:adverse effects; D012964:Sodium / Q000097:blood; D013565:Sympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D001593:Benzyl Compounds; D004232:Diuretics; D005292:Ferricyanides; D006146:Guanidines; D013565:Sympatholytics; D014665:Vasodilator Agents; D006830:Hydralazine; D009569:Nitric Oxide; D008750:Methyldopa; D008914:Minoxidil; D012110:Reserpine; D012964:Sodium; D011433:Propranolol; D003000:Clonidine; D003981:Diazoxide; D006145:Guanethidine